Physician profile
Fitza Faiz
NPI 1255787842
$2,747.41
in general payments reported to CMS, 2019-2025
29 companies · $459 in 2025
The $459 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $450 · 2022: $852 · 2023: $514 · 2024: $473 · 2025: $459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,356 · Education: $90.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,355.84 |
| Education | $90.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $376.61 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $322.27 | 2022-2025 | |
| Mayne Pharma Commercial LLC | $297.53 | 2021-2025 | |
| Aspira Women'S Health INC | $279.94 | 2022-2024 | Ova1 |
| Astellas Pharma US INC | $256.76 | 2023-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $182.68 | 2021-2025 | |
| Organon LLC | $144.35 | 2022-2025 | Nexplanon |
| Novo Nordisk INC | $131.55 | 2022-2024 | Wegovy |
| Exeltis, USA INC. | $103.82 | 2021-2025 | Slynd |
| Biogen, INC. | $80.03 | 2024-2025 | Zurzuvae |
| Therapeuticsmd, INC. | $72.85 | 2021-2022 | |
| Shield Therapeutics INC | $60.37 | 2022-2024 | |
| Evofem Biosciences, INC. | $53.79 | 2022-2025 | Phexxi, Solosec, Phexx |
| Channel Medsystems, INC. | $41.70 | 2023 | |
| Lilly USA, LLC | $37.93 | 2024-2025 | Zepbound |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $34.03 | 2021 | |
| Daiichi Sankyo INC. | $32.90 | 2021-2022 | |
| Medtronic, INC. | $30.29 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $23.57 | 2022 | |
| Agile Therapeutics, INC. | $22.53 | 2021 | |
| Abbott Laboratories | $21.05 | 2024 | Freestyle Libre 3 |
| Sage Therapeutics, LLC | $20.40 | 2021 | |
| Coopersurgical, INC. | $19.33 | 2022 | |
| Lsi Solutions INC | $19.11 | 2024 | Fornisee |
| Mylan Pharmaceuticals INC. | $17.81 | 2021 | |
| Hologic Sales and Service, LLC | $16.85 | 2024 | Acessa Provu System, Novasure, Myosure Tissue Removal Device |
| Urovant Sciences INC | $16.46 | 2021 | |
| Exact Sciences Corporation | $15.86 | 2023 | Cologuard Collection Kit |
| Lupin INC. | $15.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fitza Faiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.